Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

A New Technique to Diagnose Acute and Chronic Deep Vein Thrombosis

Conditions:   Deep Vein Thrombosis;   Compression Ultrasound;   Elastography;   Elasticity Imaging Techniques
Intervention:   Other: ultrasound elastography
Sponsor:   Azienda Sanitaria Locale ASL 6, Livorno
Recruiting - verified June 2016

Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery

Conditions:   Pregnancy Complications;   Hemorrhage
Interventions:   Drug: tranexamic acid 1 g (TA1);   Drug: tranexamic acid 0.5 g (TA1/2);   Drug: Saline Solution (TA0)
Sponsors:   University Hospital, Lille;   Ministry of Health, France;   French Health Products Safety Agency
Recruiting - verified June 2016

Use of Bemiparine as a Profilaxix Antitrombotic Agent, in Microsurgery for Head and Neck Reconstruction

Condition:   Patients Undergoing Microvascular Surgery
Sponsors:   Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal;   Rovi Pharmaceuticals Laboratories
Recruiting - verified June 2016

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

Condition:   Venous Thrombosis and Pulmonary Embolism
Intervention:   Drug: Rivaroxaban (Xarelto, BAY 59-7939)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Not yet recruiting - verified June 2016

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

Condition:   Venous Thromboembolism
Sponsor:   Boehringer Ingelheim
Recruiting - verified June 2016

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Condition:   Cancer
Interventions:   Drug: Rivaroxaban;   Drug: Placebo
Sponsors:   Janssen Research & Development, LLC;   Bayer
Recruiting - verified June 2016

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Condition:   Transcatheter Aortic Valve Replacement
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting - verified June 2016

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial

Conditions:   Renal Cell Carcinoma;   Kidney Cancer
Interventions:   Drug: Sunitinib;   Drug: Isoquercetin;   Drug: Placebo
Sponsors:   Consorzio Oncotech;   Clinical Research Technology
Not yet recruiting - verified June 2016

PERC Rule to Exclude Pulmonary Embolism in the Emergency Deparment

Condition:   Emergency Patients
Intervention:   Other: PERC based Strategy
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2016

Personalized Medicine Decision-Making in a Virtual Clinical Setting

Conditions:   Deep Vein Thrombosis;   Blood Clots
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting - verified June 2016

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Conditions:   Rivaroxaban;   Cancer-associated Thrombosis;   Recurrence;   Bleeding
Intervention:   Drug: Rivaroxaban
Sponsors:   Seoul National University Hospital;   Korean Society of Hematology Thrombosis Working Party
Active, not recruiting - verified June 2016

Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma Patients

Conditions:   Venous Thromboembolism;   Pulmonary Embolus;   Deep Vein Thrombosis
Sponsors:   Scripps Health;   Lancaster General Hospital;   University of Florida;   Medical University of South Carolina;   Portland VA Medical Center;   Stanford University;   Johns Hopkins University;   Massachusetts General Hospital;   The University of Texas Health Science Center, Houston;   Medical College of Wisconsin;   Oregon Health and Science University;   Christiana Care Health Services;   San Francisco General Hospital;   University of Utah;   Carolinas Medical Center
Withdrawn - verified June 2016